Find policies, billing codes, payers, states, and providers
CPT 51784: Anal or Urethral Sphincter Electrical Activity Testing
CPT code 51784 denotes electrodiagnostic measurement of the electrical activity in the anal or urethral sphincter muscles. This diagnostic procedure is used in evaluating neuromuscular function of pelvic sphincters and can inform care for patients with neurogenic bladder, fecal incontinence, or other pelvic floor neuromuscular disorders. Nationally, accurate coding of sphincter EMG supports appropriate clinical documentation, care planning, and claims processing for specialty outpatient services.
Key payers discussed include Aetna, Blue Cross Blue Shield, Cigna Health, United Healthcare, and Medicare. The publication provides a concise overview of coding context, common clinical indications, related procedure codes, and payer coverage considerations. Readers will find benchmarks and comparisons where available, notes on clinical context and typical sites of service, and a clear mapping to related electrodiagnostic and pelvic floor procedures.
This summary is intended for clinicians, billing professionals, and policy analysts seeking a national-level briefing on CPT code 51784. It highlights the clinical purpose of the code, the primary payers included in the analysis, and the areas of operational impact such as documentation and code selection. Data not available in the input is noted where appropriate in the detailed sections.
Customize your policy alerts
Sign up for cpt 51784 policy alerts
Get alerted when payer policies referencing 51784 are released or updated.
Monitor payer policy activity
Billing Code Overview
CPT code 51784 measures the electrical activity of the anal or urethral sphincter muscles, typically performed as part of pelvic floor or neuromuscular evaluation. The service type is diagnostic electrodiagnostic testing of sphincter musculature. The typical site of service is an outpatient specialty setting such as a urology, colorectal surgery, or proctology clinic where neuromuscular testing is performed.
National Reimbursement Benchmarks
Medicare’s national mean rate of $45.8 sits well below BUCA’s average commercial mean of $155.6, highlighting a substantial gap between federal reimbursement and this commercial benchmark. The difference of $109.8 in mean rates underscores that Medicare is closer to the lower end of the payer spectrum, while BUCA represents a higher-cost commercial average for CPT 51784.
Examining dispersion using the interquartile spread (P75 minus P25) highlights variation across payers: Blue Cross Blue Shield’s spread is $61.0 (P75 $217.9 minus P25 $157.1), UnitedHealth Group’s spread is $80.0 (P75 $135.8 minus P25 $53.8), Aetna’s spread is $64.0, Cigna’s spread is $92.1, and BUCA’s spread is $69.1. Cigna shows the widest IQR at $92.1, indicating the largest mid‑range variability, while Blue Cross Blue Shield is relatively tightest at $61.0.